(PDF) Assessing Tumor Heterogeneity Using ctDNA to Predict

Assessing Tumor Heterogeneity Using ctDNA to Predict and Monitor Therapeutic Response in Metastatic Breast Cancer

International Journal of Cancer - United States

doi 10.1002/ijc.32536

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

July 4, 2019

Authors

Publisher

Wiley

Related search

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Frontiers in Genetics

Molecular Medicine

English

Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery

Journal of the National Comprehensive Cancer Network : JNCCN

English

Diffuse Reflectance Spectroscopy to Monitor Murine Colorectal Tumor Progression and Therapeutic Response

Journal of Biomedical Optics

Molecular Physics,

Magnetic Materials

Biomedical Engineering

English

A Prospective Study of Bone Tumor Response Assessment in Metastatic Breast Cancer

Clinical Breast Cancer

Cancer Research

English

Circulating Tumor and Endothelial Cells as Predictors of Response in Metastatic Breast Cancer

Breast Cancer Research

Cancer Research

English

Microenvironmental Networks Promote Tumor Heterogeneity and Enrich for Metastatic Cancer Stem-Like Cells in Luminal-A Breast Tumor Cells

English

Diffuse Reflectance Spectroscopy to Monitor Murine Colorectal Tumor Progression and Therapeutic Response (Erratum)

Journal of Biomedical Optics

Molecular Physics,

Magnetic Materials

Biomedical Engineering

English

Clinical Factors Associated With Circulating Tumor DNA (ctDNA) in Primary Breast Cancer

Molecular Oncology

Cancer Research

Molecular Medicine

English

Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers

Cancer Research

English